LAB
Standard BioTools Inc.$0.61-0.10 (-14.48%)Prev Close$0.71·MCap$279.3M·P/E4.50·Vol510.6K·Yield—
▲
Buys (12M)
1
$46.9K
▼
Sells (12M)
3
$122.8K
◆
Net Activity
Net Seller
$75.9K
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Standard BioTools Inc. (LAB) has been dominated by selling, with 1 insider purchase totaling $46.9K and 3 insider sales totaling $122.8K. The most recent insider transaction was by Carey Thomas D. (director), who purchased $46.9K worth of shares on Nov 5, 2026. Standard BioTools Inc. operates in the Healthcare sector, within the Medical - Specialties industry, with a market cap of $279.3M.
LAB Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Carey Thomas D. | director | Buy | 75,000 | $0.63 | $46.9K | 419,456 |
| Nov 20, 2025 | Egholm Michael | President & CEO | Sell | 63,529 | $1.28 | $81.3K | 0 |
| Nov 20, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 12,739 | $1.28 | $16.3K | 0 |
| Nov 20, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 19,661 | $1.28 | $25.2K | 0 |
| Aug 20, 2025 | Egholm Michael | President & CEO | Sell | 54,919 | $1.27 | $69.7K | 0 |
| Aug 20, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 12,739 | $1.27 | $16.2K | 0 |
| Aug 20, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 19,661 | $1.27 | $25.0K | 0 |
| May 28, 2025 | Egholm Michael | President & CEO | Sell | 9,906 | $1.09 | $10.8K | 0 |
| May 28, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 2,583 | $1.09 | $2.8K | 0 |
| May 28, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 23,919 | $1.09 | $26.1K | 0 |
| May 23, 2025 | Egholm Michael | President & CEO | Sell | 5,473 | $0.94 | $5.2K | 0 |
| May 23, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,428 | $0.94 | $1.3K | 0 |
| May 23, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 13,217 | $0.94 | $12.4K | 0 |
| May 22, 2025 | Egholm Michael | President & CEO | Sell | 5,116 | $1.00 | $5.1K | 0 |
| May 22, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,355 | $1.00 | $1.4K | 0 |
| May 21, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 25,374 | $1.02 | $25.8K | 0 |
| May 20, 2025 | Egholm Michael | President & CEO | Sell | 23,062 | $1.05 | $24.1K | 0 |
| May 20, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 7,771 | $1.05 | $8.1K | 0 |
| Apr 4, 2025 | Egholm Michael | President & CEO | Sell | 57,676 | $1.07 | $61.7K | 0 |
| Apr 4, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 21,441 | $1.07 | $22.9K | 0 |
| Feb 20, 2025 | Egholm Michael | President & CEO | Sell | 31,031 | $1.39 | $43.1K | 0 |
| Aug 29, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 250,000 | $2.19 | $546.8K | 54,025,820 |
| Aug 26, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 750,000 | $2.06 | $1.55M | 53,775,820 |
| Aug 21, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,250,000 | $1.88 | $2.35M | 53,025,820 |
| Aug 16, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,200,000 | $1.59 | $1.91M | 51,775,820 |
| Aug 13, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,575,408 | $1.62 | $2.56M | 50,575,820 |
| Aug 9, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,069,562 | $1.61 | $1.72M | 49,000,412 |
| Aug 6, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,200,000 | $1.62 | $1.95M | 47,930,820 |
| May 28, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 100,000 | $2.60 | $260.0K | 46,075,820 |
| May 22, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 600,000 | $2.57 | $1.54M | 45,975,820 |
| May 17, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,352,072 | $2.56 | $3.46M | 45,375,820 |
| Mar 6, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 251,403 | $2.57 | $646.2K | 11,497,928 |
| May 22, 2023 | Black Jeffrey G. | SVP & Chief Financial Officer | Buy | 85,984 | $2.25 | $193.6K | 85,984 |
| May 19, 2023 | Casdin Eli | Director | Buy | 1,200,000 | $2.19 | $2.63M | 1,200,000 |
| Aug 5, 2022 | Caligan Partners LP | 10% Owner | Buy | 301,182 | $1.75 | $526.6K | 11,444,836 |
| Aug 2, 2022 | Caligan Partners LP | 10% Owner | Buy | 620,466 | $1.54 | $953.6K | 11,143,654 |
| Jun 15, 2022 | Caligan Partners LP | 10% Owner | Buy | 100,000 | $1.70 | $170.0K | 10,523,188 |
| Jun 6, 2022 | Caligan Partners LP | 10% Owner | Buy | 450,000 | $1.95 | $879.0K | 10,423,188 |
| May 10, 2022 | Caligan Partners LP | 10% Owner | Buy | 488,350 | $2.88 | $1.41M | 9,973,188 |
| May 2, 2022 | Caligan Partners LP | 10% Owner | Buy | 400,000 | $2.69 | $1.08M | 9,484,838 |
| Apr 13, 2022 | Caligan Partners LP | 10% Owner | Buy | 195,000 | $3.80 | $741.1K | 9,084,838 |
| Apr 8, 2022 | Caligan Partners LP | 10% Owner | Buy | 509,573 | $3.77 | $1.92M | 8,889,838 |
LAB Insider Buying Activity
The following table shows recent insider purchases of Standard BioTools Inc. (LAB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Carey Thomas D. | director | Buy | 75,000 | $0.63 | $46.9K | 419,456 |
| Aug 29, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 250,000 | $2.19 | $546.8K | 54,025,820 |
| Aug 26, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 750,000 | $2.06 | $1.55M | 53,775,820 |
| Aug 21, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,250,000 | $1.88 | $2.35M | 53,025,820 |
| Aug 16, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,200,000 | $1.59 | $1.91M | 51,775,820 |
| Aug 13, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,575,408 | $1.62 | $2.56M | 50,575,820 |
| Aug 9, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,069,562 | $1.61 | $1.72M | 49,000,412 |
| Aug 6, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,200,000 | $1.62 | $1.95M | 47,930,820 |
| May 28, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 100,000 | $2.60 | $260.0K | 46,075,820 |
| May 22, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 600,000 | $2.57 | $1.54M | 45,975,820 |
| May 17, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 1,352,072 | $2.56 | $3.46M | 45,375,820 |
| Mar 6, 2024 | Casdin Partners Master Fund, L.P. | Director | Buy | 251,403 | $2.57 | $646.2K | 11,497,928 |
| May 22, 2023 | Black Jeffrey G. | SVP & Chief Financial Officer | Buy | 85,984 | $2.25 | $193.6K | 85,984 |
| May 19, 2023 | Casdin Eli | Director | Buy | 1,200,000 | $2.19 | $2.63M | 1,200,000 |
| Aug 5, 2022 | Caligan Partners LP | 10% Owner | Buy | 301,182 | $1.75 | $526.6K | 11,444,836 |
| Aug 2, 2022 | Caligan Partners LP | 10% Owner | Buy | 620,466 | $1.54 | $953.6K | 11,143,654 |
| Jun 15, 2022 | Caligan Partners LP | 10% Owner | Buy | 100,000 | $1.70 | $170.0K | 10,523,188 |
| Jun 6, 2022 | Caligan Partners LP | 10% Owner | Buy | 450,000 | $1.95 | $879.0K | 10,423,188 |
| May 10, 2022 | Caligan Partners LP | 10% Owner | Buy | 488,350 | $2.88 | $1.41M | 9,973,188 |
| May 2, 2022 | Caligan Partners LP | 10% Owner | Buy | 400,000 | $2.69 | $1.08M | 9,484,838 |
| Apr 13, 2022 | Caligan Partners LP | 10% Owner | Buy | 195,000 | $3.80 | $741.1K | 9,084,838 |
| Apr 8, 2022 | Caligan Partners LP | 10% Owner | Buy | 509,573 | $3.77 | $1.92M | 8,889,838 |
LAB Insider Selling Activity
The following table shows recent insider sales of Standard BioTools Inc. (LAB) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Egholm Michael | President & CEO | Sell | 63,529 | $1.28 | $81.3K | 0 |
| Nov 20, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 12,739 | $1.28 | $16.3K | 0 |
| Nov 20, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 19,661 | $1.28 | $25.2K | 0 |
| Aug 20, 2025 | Egholm Michael | President & CEO | Sell | 54,919 | $1.27 | $69.7K | 0 |
| Aug 20, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 12,739 | $1.27 | $16.2K | 0 |
| Aug 20, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 19,661 | $1.27 | $25.0K | 0 |
| May 28, 2025 | Egholm Michael | President & CEO | Sell | 9,906 | $1.09 | $10.8K | 0 |
| May 28, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 2,583 | $1.09 | $2.8K | 0 |
| May 28, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 23,919 | $1.09 | $26.1K | 0 |
| May 23, 2025 | Egholm Michael | President & CEO | Sell | 5,473 | $0.94 | $5.2K | 0 |
| May 23, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,428 | $0.94 | $1.3K | 0 |
| May 23, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 13,217 | $0.94 | $12.4K | 0 |
| May 22, 2025 | Egholm Michael | President & CEO | Sell | 5,116 | $1.00 | $5.1K | 0 |
| May 22, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 1,355 | $1.00 | $1.4K | 0 |
| May 21, 2025 | Mackay Sean | SVP & Chief Business Officer | Sell | 25,374 | $1.02 | $25.8K | 0 |
| May 20, 2025 | Egholm Michael | President & CEO | Sell | 23,062 | $1.05 | $24.1K | 0 |
| May 20, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 7,771 | $1.05 | $8.1K | 0 |
| Apr 4, 2025 | Egholm Michael | President & CEO | Sell | 57,676 | $1.07 | $61.7K | 0 |
| Apr 4, 2025 | Kim Hanjoon Alex | Chief Financial Officer | Sell | 21,441 | $1.07 | $22.9K | 0 |
| Feb 20, 2025 | Egholm Michael | President & CEO | Sell | 31,031 | $1.39 | $43.1K | 0 |
LAB Insiders
Similar Stocks to LAB
LLY
Eli Lilly and Company
$1430.73-0.91%
$1.35T
JNJ
Johnson & Johnson
$282.90-1.01%
$675.03B
ABBV
AbbVie Inc.
$294.54-0.22%
$521.41B
UNH
UnitedHealth Group Incorporated
$410.34+0.70%
$361.04B
TMO
Thermo Fisher Scientific Inc.
$689.69-1.52%
$265.92B
GILD
Gilead Sciences, Inc.
$167.25-0.55%
$210.52B
DHR
Danaher Corporation
$230.28-1.28%
$165.55B
ISRG
Intuitive Surgical, Inc.
$437.07-1.43%
$155.83B